Effects of Long-term Norfloxacin Therapy in Patients with Advanced Cirrhosis.
Fiche publication
Date publication
août 2018
Journal
Gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRONOWICKI Jean-Pierre, Pr DI MARTINO Vincent
Tous les auteurs :
Moreau R, Elkrief L, Bureau C, Perarnau JM, Thévenot T, Saliba F, Louvet A, Nahon P, Lannes A, Anty R, Hillaire S, Pasquet B, Ozenne V, Rudler M, Ollivier-Hourmand I, Robic MA, d'Alteroche L, Di Martino V, Ripault MP, Pauwels A, Grangé JD, Carbonell N, Bronowicki JP, Payancé A, Rautou PE, Valla D, Gault N, Lebrec D,
Lien Pubmed
Résumé
There is debate over the effects of long-term oral fluoroquinolone therapy in patients with advanced cirrhosis. We performed a randomized controlled trial to evaluate the effects of long-term treatment with the fluoroquinolone norfloxacin on survival of patients with cirrhosis.
Mots clés
Inflammation, Liver-Related Complications, NORFLOCIR Trial, Risk Factor
Référence
Gastroenterology. 2018 Aug 22;: